Skip to main content

Animations

MJFF Publications

8571 - 8580 of 8808 Results
Title
Year
  • Year
  • 2018
  • 2022
  • 2016
  • 2018
  • 2019
  • 2021
  • 2017
  • 2023
  • 2022
  • 2025
  • Summary Details
    OPEN
    Title: PKA-RII subunit phosphorylation precedes activation by cAMP and regulates activity termination
    Journal Name: Journal of Cell Biology
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1083/jcb.201708053
    Citation Count: 72
  • Summary Details
    OPEN
    Title: A unifying model for the role of the ATG8 system in autophagy
    Journal Name: Journal of Cell Science
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1242/jcs.258997
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Systems-level neurophysiological state characteristics for drug evaluation in an animal model of levodopa-induced dyskinesia
    Journal Name: Journal of Neurophysiology
    Publisher: American Physiological Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1152/jn.00868.2015
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's disease
    Journal Name: European Journal of Medical Genetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.ejmg.2018.05.005
    Citation Count: 61
  • Summary Details
    OPEN
    Title: Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian Disorders
    Journal Name: Journal of Neuroimmune Pharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s11481-019-09835-4
    Citation Count: 84
  • Summary Details
    RESTRICTED
    Title: Generation of human midbrain organoids from induced pluripotent stem cells
    Journal Name: MNI Open Research
    Publisher: F1000 Research Ltd
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.12688/mniopenres.12816.2
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson's disease kinase
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1042/bcj20170802
    Citation Count: 150
  • Summary Details
    OPEN
    Title: Elevated urine BMP phospholipids in LRRK2 and VPS35 mutation carriers with and without Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00482-4
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Gender Differences in the Prevalence of Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13584
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Parkinson's‐Linked LRRK2 and GBA1 Mutations Modulate the Peripheral Immune Response to Pseudomonas aeruginosa
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.70123
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.